11月 2025
- 首頁
- AllCells
11月 2025AllCells的市場佔有率分析
Purchase high quality human primary cells from peripheral blood and bone marrow for medical, scientific, and academic research. Cryopreserved and fresh cells delivered on time and on budget.
AllCells(包含公司地區)
查看更多網站流量與參與度資訊- allcells.com
AllCells截至 11月 2025 的總收入為 15M - 25M
AllCells 熱門網域產生的總收入
AllCells 熱門網域 3 年內的總收入
AllCells 熱門網域的總收入
AllCells的熱門網域總造訪量
了解AllCells市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
AllCells的熱門網域平均造訪時長
分析AllCells參與度指標。
過去 3 個月平均造訪時長
子公司細目
AllCells的熱門網域平均頁面瀏覽量
了解AllCells如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自AllCells
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞AllCells, LLC launched Pre-Characterized Donor Selection Program on Jul 3rd '23.AllCells has recently introduced the Pre-Characterized Donor Selection Program designed to expedite screening, selecting, and collecting from eligible donors (Figure 1) for downstream clinical manufacturing.
8月 3, 2023閱讀更多
新聞AllCells, LLC expands facilities to Houston, Texas, United States.AllCells®, a Discovery Life Sciences™ company and leading provider of critical starting material and services for cell and gene therapy (CGT), has announced the expansion of its apheresis network with the addition of two new centers in Houston, Texas, and Huntsville, Alabama.
2月 22, 2023閱讀更多
新聞Discoverylifesciences acquired AllCells, LLC on Jul 1st '22.Ares served as the administrative agent, lead arranger, and bookrunner for a senior secured credit facility to support Discovery Life Sciences’ acquisition of AllCells.
10月 27, 2022閱讀更多
查看所有AllCells信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。